Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative Bioavailability, Food Effect, and PPI Interaction Study of PF-07799933
NCT07563894Phase 1Completed
- Sponsor
- Pfizer
- Start
- Apr 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of PF-07799933 (5 cohorts), sponsored by Pfizer. Primary endpoints: Area Under the Curve From Time Zero to Extrapolated Infinite Time, Area Under the Curve From Time Zero to The Last Measured Time Point and 1 more. Started Apr 2026; status: completed.
02
Drugs
PF-07799933
Beyond the preview
Go deeper on NCT07563894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07563894.